More than 300,000 babies globally are born every year with sickle cell disease, yet access to care remains limited across Sub-Saharan Africa, a region which carries over three quarters of the global disease burden. Routinely screening babies is a first step towards ensuring they receive the care needed to manage their illness and improve their quality of life – this is especially important because the biggest burden is carried by the most fragile population, babies, and children. Fortunately for Kadden, his case was detected early due to screening initiated by his mother, Rosalind, when he was 4 months old. Kadden is now 13 years old and is a success story of a patient living with a well-managed sickle cell condition. Learn more about how the early detection of sickle cell has helped Kadden live a better-quality life: https://bit.ly/3P06yPi ©2023 Novartis AG

 6140      52